Search results
Results from the WOW.Com Content Network
Riegel v. Medtronic, Inc., 552 U.S. 312 (2008), is a United States Supreme Court case in which the Court held that the pre-emption clause of the Medical Device Amendment bars state common-law claims that challenge the effectiveness or safety of a medical device marketed in a form that received premarket approval from the Food and Drug Administration.
When Army physician Timothy R. Kuklo was trying to get his study of Medtronic Inc.'s (MDT) Infuse bone-graft product published, he didn't say a word that he had received $800,000 from the medical ...
Medtronic (NYS: MDT) announced Wednesday that it is offering a $2.5 million grant to Yale researchers who will independently review the safety of the company's controversial Infuse bone graft product.
In 2007, Medtronic purchased Kyphon, a manufacturer and seller of spinal implants that are necessary for procedures like kyphoplasty. [77] In May 2008, Medtronic Spine agreed to pay the US government $75 million to settle a qui tam lawsuit after a whistleblower alleged that Medtronic committed Medicare fraud. The company was charged with ...
Medtronic, Inc. v. Mirowski Family Ventures, LLC; R. Riegel v. Medtronic, Inc. This page was last edited on 4 April 2016, at 22:38 (UTC). Text is available under ...
Text messages, a whistleblower lawsuit and an internal investigation reveal the lengths to which Medtronic, the world’s largest medical device company, allegedly “groomed” doctors to overuse ...
In 1991, Medtronic and Mirowski entered into an agreement permitting Medtronic to practice certain Mirowski patents in exchange for royalty payments. In 2007, the parties found themselves in the midst of an "infringement" dispute, and Mirowski gave Medtronic notice that it believed seven new Medtronic products violated various claims contained in two of its patents, [a] which dealt with ...
24/7 Help. For premium support please call: 800-290-4726